Cyclacel Pharma (CYCC) Shares Trade Strong Following Tang Capital 13G Filing

August 22, 2016 10:32 AM EDT

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Cyclacel Pharma (NASDAQ: CYCC) shares are up over 32 percent Monday following a 13G filing late last Friday which had hedge fund Tang Capital Management LLC disclosing a 9.6%, or 300,000 share, stake in the company. The firm did not hold shares at the end of the latest quarter ending June 30, 2016.

For more notable holders of Cyclacel Pharma stock click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

13Gs, Hedge Funds, Momentum Movers

Related Entities

Tang Capital, 13G

Add Your Comment